Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.96 | 73.53 |
| PEG Ratio (TTM) | -0.14 | 26.28 |
| P/S Ratio (TTM) | 0.33 | 10.02 |
| P/B Ratio (TTM) | 1.00 | 13.75 |
| P/FCF Ratio (TTM) | N/A | 250.43 |
| Price to 5YR AVG Earnings Ratio | 2.40 | 139.67 |
| Price to 5YR AVG FCF Ratio | -0.50 | 243.38 |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -8.87% | 7.52% |
| ROE (TTM) | -24.15% | 18.01% |
| Net Profit Margin (TTM) | -8.51% | -29.93% |
| ROIC 5YR AVG | 1.48% | 15.53% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -4.65% | 47.72% | -81.01% |
| Revenue | 13.07% | 36.59% | 15.80% |
| Net Income | -3.95% | 59.03% | -78.88% |
| Cash Flow | N/A | 776.40% | 418.11% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.33 | 1.68 |
| Quick Ratio (TTM) | 0.94 | 1.29 |
| D/E Ratio (TTM) | 0.46 | 0.58 |
| Interest Coverage (TTM) | -64.87 | 23.35 |
| Piotroski F-Score | 4 | 5 |
| Altman Z-Score | 0.53 | 13.10 |
| LTL to 5YR AVG FCF | 0.00 | -2.51 |
| Shares Outstanding Growth 5YR AVG | 26.32% | 3.30% |